JP2019516406A5 - - Google Patents

Download PDF

Info

Publication number
JP2019516406A5
JP2019516406A5 JP2019512943A JP2019512943A JP2019516406A5 JP 2019516406 A5 JP2019516406 A5 JP 2019516406A5 JP 2019512943 A JP2019512943 A JP 2019512943A JP 2019512943 A JP2019512943 A JP 2019512943A JP 2019516406 A5 JP2019516406 A5 JP 2019516406A5
Authority
JP
Japan
Prior art keywords
biomarkers
expression
classifier
sample
biomarker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019512943A
Other languages
English (en)
Japanese (ja)
Other versions
JP7241352B2 (ja
JP2019516406A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/033107 external-priority patent/WO2017201164A1/en
Publication of JP2019516406A publication Critical patent/JP2019516406A/ja
Publication of JP2019516406A5 publication Critical patent/JP2019516406A5/ja
Application granted granted Critical
Publication of JP7241352B2 publication Critical patent/JP7241352B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019512943A 2016-05-17 2017-05-17 肺扁平上皮癌のサブタイピングのための方法 Active JP7241352B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201662337645P 2016-05-17 2016-05-17
US62/337,645 2016-05-17
US201662379402P 2016-08-25 2016-08-25
US62/379,402 2016-08-25
US201662396587P 2016-09-19 2016-09-19
US62/396,587 2016-09-19
US201662420836P 2016-11-11 2016-11-11
US62/420,836 2016-11-11
US201662425717P 2016-11-23 2016-11-23
US62/425,717 2016-11-23
PCT/US2017/033107 WO2017201164A1 (en) 2016-05-17 2017-05-17 Methods for subtyping of lung squamous cell carcinoma

Publications (3)

Publication Number Publication Date
JP2019516406A JP2019516406A (ja) 2019-06-20
JP2019516406A5 true JP2019516406A5 (https=) 2020-06-25
JP7241352B2 JP7241352B2 (ja) 2023-03-17

Family

ID=60325556

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019512943A Active JP7241352B2 (ja) 2016-05-17 2017-05-17 肺扁平上皮癌のサブタイピングのための方法

Country Status (6)

Country Link
US (2) US11041214B2 (https=)
EP (1) EP3458611B1 (https=)
JP (1) JP7241352B2 (https=)
CN (1) CN109863251B (https=)
CA (1) CA3024744A1 (https=)
WO (1) WO2017201164A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10829819B2 (en) 2014-05-30 2020-11-10 Genecentric Therapeutics, Inc. Methods for typing of lung cancer
AU2016343937B2 (en) 2015-10-30 2023-01-19 Exact Sciences Corporation Multiplex amplification detection assay and isolation and detection of DNA from plasma
US11041214B2 (en) 2016-05-17 2021-06-22 Genecentric Therapeutics, Inc. Methods for subtyping of lung squamous cell carcinoma
CN109790583B (zh) 2016-05-17 2023-08-25 基因中心治疗公司 对肺腺癌亚型分型的方法
CA3090912A1 (en) 2018-02-13 2019-08-22 Genecentric Therapeutics, Inc. Methods for subtyping of bladder cancer
CA3115922A1 (en) 2018-10-09 2020-04-16 Genecentric Therapeutics, Inc. Detecting cancer cell of origin
DE102018125324A1 (de) * 2018-10-12 2020-04-16 Universität Rostock Verfahren zur Vorhersage einer Antwort auf die Therapie von Krankheiten
WO2021041726A1 (en) * 2019-08-27 2021-03-04 Exact Sciences Development Company, Llc Characterizing methylated dna, rna, and proteins in subjects suspected of having lung neoplasia
CN111369501B (zh) * 2020-02-24 2022-04-01 武汉大学 一种基于视觉特征识别口腔鳞状细胞癌的深度学习方法
CN111653312B (zh) * 2020-05-28 2021-04-16 上海宝藤生物医药科技股份有限公司 一种利用基因组数据探究疾病亚型亲缘性的方法
CN111755073B (zh) * 2020-05-31 2022-11-15 复旦大学 基于转录组的pd-1疗法治疗效果预测系统
CN112433054A (zh) * 2020-11-20 2021-03-02 四川大学华西医院 C9蛋白检测试剂在制备肺癌筛查试剂盒中的用途
WO2022226391A1 (en) * 2021-04-23 2022-10-27 The Trustees Of Columbia University In The City Of New York Methods for detecting squamous cancer
CN115308418B (zh) * 2022-07-07 2024-11-08 翁良 一种生物标志物及其在肺鳞癌诊断中的应用
CN115982644B (zh) * 2023-01-19 2024-04-30 中国医学科学院肿瘤医院 一种食管鳞状细胞癌分类模型构建与数据处理方法
CN116129998B (zh) * 2023-01-19 2024-06-11 中国医学科学院肿瘤医院 一种食管鳞状细胞癌数据的处理方法及其系统
CN116287253B (zh) * 2023-02-22 2024-06-28 武汉科技大学 一种肺癌分子标志物及其应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4843155A (en) 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
JP2001524926A (ja) 1991-09-18 2001-12-04 アフィマックス テクノロジーズ ナームロゼ フェンノートシャップ オリゴマーの雑多ライブラリーの集合体を合成する方法
DE69233501T2 (de) 1991-11-22 2006-02-23 Affymetrix, Inc. (n.d.Ges.d.Staates Delaware), Santa Clara Kombinatorische Strategien für die Polymersynthese
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
EP1027456B1 (en) 1997-10-31 2005-03-16 Affymetrix, Inc. (a Delaware Corporation) Expression profiles in adult and fetal organs
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
US6670321B1 (en) 1998-12-30 2003-12-30 The Children's Medical Center Corporation Prevention and treatment for retinal ischemia and edema
US20030092009A1 (en) 2000-11-16 2003-05-15 Kaia Palm Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease
US7473767B2 (en) 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
US20040009489A1 (en) 2001-09-28 2004-01-15 Golub Todd R. Classification of lung carcinomas using gene expression analysis
US20060024692A1 (en) 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
JP2007006792A (ja) 2005-06-30 2007-01-18 Hitachi Software Eng Co Ltd 肺腺癌の胸膜浸潤を判別するための遺伝子セット
US8822153B2 (en) 2007-06-01 2014-09-02 The University Of North Carolina At Chapel Hill Molecular diagnosis and typing of lung cancer variants
WO2009046738A1 (en) 2007-10-09 2009-04-16 Curevac Gmbh Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
US20110224313A1 (en) 2008-06-05 2011-09-15 British Columbia Cancer Agency Branch Compositions and methods for classifying lung cancer and prognosing lung cancer survival
CN101509035A (zh) 2008-09-05 2009-08-19 中国人民解放军总医院 肺癌分型的基因序列及其应用
US9846162B2 (en) * 2012-05-14 2017-12-19 Yale University Immune biomarkers and assays predictive of clinical response to immunotherapy for cancer
EP2861992A4 (en) 2012-06-18 2016-06-08 Univ North Carolina PROCEDURE FOR HEAD AND NECK CANCER PROGNOSIS
EP2806274A1 (en) 2013-05-24 2014-11-26 AIT Austrian Institute of Technology GmbH Lung cancer diagnostic method and means
US20150057335A1 (en) 2013-08-20 2015-02-26 National Cancer Center Novel fusion genes identified in lung cancer
PT3142751T (pt) 2014-05-13 2019-10-25 Medimmune Ltd Anticorpos anti-b7-h1 e anti-ctla-4 para o tratamento de cancro de pulmão de não pequenas células.
EP3149042B1 (en) 2014-05-29 2019-08-28 Spring Bioscience Corporation Pd-l1 antibodies and uses thereof
US10829819B2 (en) 2014-05-30 2020-11-10 Genecentric Therapeutics, Inc. Methods for typing of lung cancer
TWI716362B (zh) 2014-10-14 2021-01-21 瑞士商諾華公司 針對pd-l1之抗體分子及其用途
WO2016168446A1 (en) 2015-04-14 2016-10-20 Genecentric Diagnostics, Inc. Methods for typing of lung cancer
US11041214B2 (en) 2016-05-17 2021-06-22 Genecentric Therapeutics, Inc. Methods for subtyping of lung squamous cell carcinoma
CN109790583B (zh) 2016-05-17 2023-08-25 基因中心治疗公司 对肺腺癌亚型分型的方法
US11739386B2 (en) 2017-07-21 2023-08-29 Genecentric Therapeutics, Inc. Methods for determining response to PARP inhibitors

Similar Documents

Publication Publication Date Title
JP2019516406A5 (https=)
JP2019516407A5 (https=)
AU2012261820B2 (en) Molecular diagnostic test for cancer
CN102149827B (zh) MiR-26家族作为肝细胞癌和对治疗的应答性的预测性标志物的用途
Lin et al. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer
Bianchini et al. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa
EP3179393B1 (en) Gene expression profile algorithm and test for determining prognosis of prostate cancer
JP7241352B2 (ja) 肺扁平上皮癌のサブタイピングのための方法
JP6144695B2 (ja) タキサン療法を用いて乳癌を処置する方法
CA2859663A1 (en) Identification of multigene biomarkers
AU2012261820A1 (en) Molecular diagnostic test for cancer
JP2016505247A5 (https=)
WO2016014705A1 (en) Characterization of melanoma using a molecular signature
CN103547682A (zh) 肝细胞癌的基因标签
US20250137066A1 (en) Compostions and methods for diagnosing lung cancers using gene expression profiles
US9410205B2 (en) Methods for predicting survival in metastatic melanoma patients
EP3146076A2 (en) Gene expression profiles associated with sub-clinical kidney transplant rejection
EP1613767B1 (en) Method of defining the differentiation grade of tumor
AU2021221905B2 (en) Gene expression profiles associated with sub-clinical kidney transplant rejection
CN110055332A (zh) 与甲状腺癌相关的标志物及其应用
CN114032308A (zh) Fam83a、kpna2、krt6a和ldha联合作为肺腺癌生物标志物的用途
CN111315897B (zh) 用于黑素瘤检测的方法
CN110129444A (zh) 一种检测放射性损伤的试剂及其应用
CN114901836A (zh) 肝移植的临床和分子预后标志物
CN113692449A (zh) 预测免疫检查点抑制疗法益处的方法